ATP Citrate Lyase (ACLY) (Middle Region) Peptide
Quick Overview for ATP Citrate Lyase (ACLY) (Middle Region) Peptide (ABIN972818)
Target
Origin
Source
Application
-
-
Protein Region
- Middle Region
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-ACLY antibody (Catalog #: ARP42737_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- ACLY (ATP Citrate Lyase (ACLY))
-
Background
-
ATP citrate lyase is the primary enzyme responsible for the synthesis of cytosolic acetyl-CoA in many tissues. The enzyme is a tetramer (relative molecular weight approximately 440,000) of apparently identical subunits. It catalyzes the formation of acety
Alias Symbols: ACL, ATPCL, CLATP
Protein Interaction Partner: ACLY,GSK3B,PRKACA,GSK3B,HGS,IKBKE,NME2,PRKAB1,TFE3
Protein Size: 1101 -
Molecular Weight
- 121 kDa
-
Gene ID
- 47
-
NCBI Accession
- NM_001096, NP_001087
-
UniProt
- P53396
Target
-